EMA to scour medical literature for potential safety concerns from popular drugs
This article was originally published in SRA
Executive Summary
The European Medicines Agency is preparing to launch a new service under which it would monitor medical literature for reports of suspected adverse reactions from drugs containing certain active substances, and then submit the relevant case reports into the EudraVigilance system on behalf of drug companies.